Symlin and Metformin for Type ! - TuDiabetes

CardioBusiness Health Magazine

NEJM: Are drugs or lifestyle changes best for obese, diabetic youths?

cardiovascularbusiness.com — “Monotherapy with metformin was associated with durable glycemic control in approximately half of children and adolescents with type 2 diabetes; however, the addition of rosiglitazone, but not an intensive lifestyle intervention, was superior to metformin alone, according to the TODAY study published online April 29 in the New England Journal of Medicine. Yet, the editorialist questioned the study’s design.” View full resource at cardiovascularbusiness.com

Most Recently Shared on May 1, 2012 at 8:00 pm By:

@NEJM Are drugs or lifestyle changes best for obese, diabetic youths? http://t.co/kGP16N3m #type2 #obese #diabetes

MNT Diabetes News Health News

Teenagers With Type 2 Diabetes Benefit From Metformin And Rosiglitazone Combo

medicalnewstoday.com — “A combination of two diabetes drugs, metformin and rosiglitazone, was more effective in treating youth with recent-onset type 2 diabetes than metformin alone, a study funded by the National Instit” View full resource at medicalnewstoday.com

Most Recently Shared on May 1, 2012 at 8:05 am By:

Teenagers With Type 2 Diabetes Benefit From Metformin And Rosiglitazone Combo http://t.co/dXESKb9f #diabetes

No Easy Cure for Diabetic Children - WSJ.com

online.wsj.com — “The only pill approved in the U.S. for treatment of children with type 2 diabetes is proving surprisingly ineffective, heightening worries about the fast-growing and largely preventable disease.” View full resource at online.wsj.com

Most Recently Shared on April 30, 2012 at 4:39 pm By:

William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor

No Panacea for Diabetic Children: Diabetic drug (metformin) surprisingly ineffective in children. http://t.co/EpSBxEmR via @WSJ

Knoxville Hospital Hospital

Kids With Type 2 Diabetes: Combo Treatment Best?

diabetes.webmd.com — “A new government-funded study finds that metformin plus Avandia is better than metformin alone for kids and teens with type 2 diabetes.” View full resource at diabetes.webmd.com

Most Recently Shared on April 29, 2012 at 7:53 pm By:

Kids With Type 2 Diabetes: Combo Treatment Best?: A new government-funded study finds that metformin plus Avandi... http://t.co/0Csv7B3n

Diabetes, Type 2 OW Health

MedWire News - Diabetes - Incretin-based therapy effective as add-on to metformin

medwire-news.md — “MedWire News Incretin-based therapy is effective at improving glycemic control when added to metformin treatment in patients with Type 2 diabetes, show study findings. MedWire News” View full resource at medwire-news.md

Most Recently Shared on April 28, 2012 at 1:46 am By:

Incretin-based therapy effective as add-on to metformin: Incretin-based therapy is effective at improving glycem... http://t.co/MItet733

Walter Adamson Patient Expert

Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned - Health News - Health.com

news.health.com — “THURSDAY, April 19 (HealthDay News) -- It's not clear whether patients with type 2 diabetes gain any long-term benefit from taking the blood sugar-lowering drug metformin and insulin together rather than insulin alone.” View full resource at news.health.com

Most Recently Shared on April 20, 2012 at 11:34 pm By:

Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned: THURSDAY, April 19 (HealthDay News) — It’s not... http://t.co/0FXprdDJ

1 month ago...

Metformin, Also for Type 1 Diabetes: A Surprising Visit to the Diabetes Clinic | A Sweet Life

asweetlife.org — “So I said, “Can I try metformin?” “You know, metformin is considered a type 2 diabetes therapy,” the doctor said. Well, it was worth a try...” View full resource at asweetlife.org

Most Recently Shared on April 19, 2012 at 4:46 pm By:

jessica apple Health Communicator and Patient Expert

more #diabetes drugs. #dblog on T1D taking #metformin http://t.co/SwmOcFiE

1 month ago...

Jane Anderson Healthy Eating Advisor

Common Diabetes Drug May Fight Cancer

webmd.com — “The diabetes drug metformin -- commonly a first choice for controlling blood sugar in people with type 2 diabetes -- is sparking new interest as a cancer fighter.” View full resource at webmd.com

Most Recently Shared on April 3, 2012 at 7:48 pm By:

Common Diabetes Drug May Fight Cancer http://t.co/J3Idr30u

Scott Strumello Patient Expert

Diabetes drug can prevent heart disease, new study suggests

sciencedaily.com — “The widely used diabetes medicine metformin can have protective effects on the heart, reveals a new study.” View full resource at sciencedaily.com

Most Recently Shared on March 26, 2012 at 3:50 pm By:

Type 2 Diabetes drug can prevent heart disease, new study suggests http://t.co/ZweMNGmR via @ScienceDaily

News-Medical.Net Health News

European Commission grants marketing authorization for use of BYETTA with basal insulin

news-medical.net — “Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.” View full resource at news-medical.net

Most Recently Shared on March 23, 2012 at 1:57 pm By:

European Commission grants marketing authorization for use of BYETTA with basal insulin: Amylin Pharmaceuticals,... http://t.co/3EqmxLdM

Diabetes, Type 2 OW Health

American Diabetes Association Increases Focus on Prevention: Two New Reports Provide Further Support for Long-Term Cost and Medical Effectiveness of Lifestyle Intervention, Medication in Preventing Type 2 Diabetes - Yahoo! Finance

finance.yahoo.com — “From Yahoo! Finance: ALEXANDRIA, VA-- - Lifestyle intervention and treatment with metformin provide safe, long-term, cost-effective means of preventing type 2 diabetes and should be incorporated into prevention strategies ...” View full resource at finance.yahoo.com

Most Recently Shared on March 23, 2012 at 12:14 am By:

American Diabetes Association Increases Focus on Prevention: Two New Reports Provide Further Support for Long-Te... http://t.co/72d2bfq5

Endocrinology News - Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus |3951559

mdlinx.com — “Endocrinology Medical Article: Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus” View full resource at mdlinx.com

Most Recently Shared on March 19, 2012 at 12:43 pm By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformi... http://t.co/1NJ9HE9o #endo

Oncology News - Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer |3982131

mdlinx.com — “Oncology Medical Article: Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer” View full resource at mdlinx.com

Most Recently Shared on March 19, 2012 at 7:05 am By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal... http://t.co/2DCvp5RG #oncology

Gastroenterology News - Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer |3982131

mdlinx.com — “Gastroenterology Medical Article: Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer” View full resource at mdlinx.com

Most Recently Shared on March 17, 2012 at 6:15 am By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cance... http://t.co/bNELOok3 #GI

Endocrinology News - Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer |3982131

mdlinx.com — “Endocrinology Medical Article: Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer” View full resource at mdlinx.com

Most Recently Shared on March 16, 2012 at 5:35 pm By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal can... http://t.co/9ebtjwx0 #endo